Label: TERADIA THE LIQUIDDIAMOND SUNSCREEN SPF50- ethylhexyl methoxycinnamate, homosalate, ethylhexyl salicylate cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 18, 2018

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Octinoxate, Homosalate, Octisalate

  • INACTIVE INGREDIENT

    Niacinamide, Adenosine

  • PURPOSE

    Sunscreen, Anti-Wrinkle, Whitening

  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of the children

  • INDICATIONS & USAGE

    At the last step of skin care, take an appropriate amount and apply evenly on the face, neck and other areas exposed to UV radiation

  • WARNINGS

    1. Do not use in the following cases(Eczema and scalp wounds)
    2.Side Effects
    1)Due to the use of this druf if rash, irritation, itching and symptopms of hypersnesitivity occur dicontinue use and consult your phamacisr or doctor
    3.General Precautions
    1)If in contact with the eyes, wash out thoroughty with water If the symptoms are servere, seek medical advice immediately
    2)This product is for exeternal use only. Do not use for internal use
    4.Storage and handling precautions
    1)If possible, avoid direct sunlight and store in cool and area of low humidity
    2)In order to maintain the quality of the product and avoid misuse
    3)Avoid placing the product near fire and store out in reach of children

  • DOSAGE & ADMINISTRATION

    for external use only


  • PRINCIPAL DISPLAY PANEL

    label

  • INGREDIENTS AND APPEARANCE
    TERADIA THE LIQUIDDIAMOND SUNSCREEN SPF50 
    ethylhexyl methoxycinnamate, homosalate, ethylhexyl salicylate cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71483-0001
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE7 g  in 100 mL
    HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE6 g  in 100 mL
    OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE4.5 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    ADENOSINE (UNII: K72T3FS567)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71483-0001-140 mL in 1 TUBE; Type 0: Not a Combination Product12/20/2017
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart35212/20/2017
    Labeler - NanoDia Lab Co Ltd (693900835)
    Registrant - NanoDia Lab Co Ltd (693900835)
    Establishment
    NameAddressID/FEIBusiness Operations
    NanoDia Lab Co Ltd693900835manufacture(71483-0001)